News: Bipartisan Drug pricing package gets advancement by Senate Committee
The drug price for medicare gets deductions in the increased price transparency by the US Senate Committee on Finance. With the vote of 19-9, the bill sees consideration by the full Senate. The Democratic minority of the committee had voted in a large number while the Committee Chairman Chuck Grassley (R-IA) and the Ranking member Ron Wyden (D-OR) were the ones to propose the Bipartisan Prescription Drug Pricing Reduction Act of 2019.
Regarding the Congressional Budget Office's estimated bill, Grassley promises lower premiums and lower out-of-pocket expenditures for healthcare and other medical beneficiaries promoting a positive effect on seniors, who consequently have a fear of getting bankrupt.